How to interpret near-vision outcomes

A clinical result is most useful when its measurement, population and testing conditions are clear. When discussing TVT®, distinguish a change on an acuity test, a study responder definition and the activities a patient wants to perform.

Identify the measurement

Record whether testing was monocular or binocular, with or without distance correction, and at which reading distance. Keep illumination, contrast and measurement timing alongside the result. The label “near vision” alone does not make two protocols equivalent.

Read TVT® within its study design

The December 2022 Presbyopia Physician article by authors with Yolia relationships describes 50 presbyopic participants in a prospective, single-site, interventional, participant-masked study funded by Yolia. It reports high-contrast binocular uncorrected near acuity in logMAR. After a seven-day treatment course, assessments occurred on days 8, 15, 30, 60, 90 and 180. The consulted report does not specify testing distance or illumination and does not describe a control arm.

Author relationships with Yolia were disclosed. General statements about no side effects do not replace a detailed adverse-event breakdown or establish universal absence of risk.

Original TVT® report. No DOI or PMID is displayed in this publication.

Recognize a different endpoint

The pooled NEAR analysis evaluated pilocarpine 0.4% against vehicle in two multicenter randomized masked trials: 613 adults aged 45–64, treated twice daily for two weeks. Testing used distance-corrected near acuity at 40 cm in a study eye under mesopic conditions. The primary endpoint was measured one hour after the first dose on day 8. Its responder definition combined near improvement with preservation of distance acuity. These conditions differ from those described for TVT®; the results cannot rank the treatments by efficacy. A two-week safety assessment does not answer every question about longer use. Authors included Orasis Pharmaceuticals affiliates.

NEAR publication · DOI: 10.1016/j.clinthera.2023.12.005 · PMID: 38216351. Methods reviewed at abstract level; full text not appraised.

Apply the reading in consultation

Document testing conditions and changes over time. Explain the patient’s own observed result and agree when to reassess. Clinical communication is clearer when every number retains its definition and expectations are linked to an individual assessment.

Sources and scope

Educational editorial · October 29, 2026. Yolia report and external literature are identified separately. Editorial review with Claude and source checking; no independent physician review.